|
MRK's Net Cash Flow Growth by Quarter and Year
Merck And Co Inc 's Net Cash Flow results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Net Cash Flow Growth Y/Y▼
|
Net Cash Flow Growth Y/Y▼
|
MRK Net Cash Flow (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
0.00
|
1,494.00
|
-1,879.00
|
764.00
|
III Quarter |
September |
2,957.00
|
1,526.00
|
1,416.00
|
-3,746.00
|
II Quarter |
June |
-4,074.00
|
1,139.00
|
1,619.00
|
3,687.00
|
I Quarter |
March |
-2,987.00
|
447.00
|
-1,142.00
|
-2,474.00
|
FY |
|
-4,104.00
|
4,606.00
|
14.00
|
-1,769.00
|
MRK Net Cash Flow fourth quarter 2023 Y/Y Growth Comment |
Merck and Co Inc in the fourth quarter 2023 recorded net cash outflow of $ 0.00 millions.
Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher Net Cash Flow growth. While Merck And Co Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 240 in the fourth quarter 2023.
|
MRK Net Cash Flow ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
- |
- |
-61.16 % |
III Quarter |
September |
93.77 % |
7.77 % |
- |
- |
II Quarter |
June |
- |
-29.65 % |
-56.09 % |
- |
I Quarter |
March |
- |
- |
- |
- |
FY |
|
- |
32800 % |
- |
- |
MRK Net Cash Flow (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
-2.1 % |
- |
- |
III Quarter |
September |
- |
33.98 % |
-12.54 % |
- |
II Quarter |
June |
- |
154.81 % |
- |
- |
I Quarter |
March |
- |
- |
- |
- |
FY (Year on Year) |
|
- |
32800 % |
- |
- |
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
(Dec 31 2022) |
|
(Sep. 30, 2007) |
|
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
(Dec 31 2022) |
|
(Sep. 30, 2007) |
|
Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Merck And Co Inc 's Q/Q Net Cash Flow Growth
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
MRK's IV. Quarter Q/Q Net Cash Flow Comment |
Current results of 0.00 millions by Merck and Co Inc look even more unfavourable considering the 2,957.00 millions a quarter before.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is . |
|
|
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
MRK's IV. Quarter Q/Q Net Cash Flow Comment |
IV. Quarter 2023 results of 0.00 millions by Merck and Co Inc appear even more unfavourable if you take a look at 2,957.00 millions net cash outflow in the previous quarter.
Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is . |
|
Merck And Co Inc 's 12 Months Net Cash Flow Growth Year on Year
Net Cash Flow TTM Growth |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
Cumulative Net Cash Flow 12 Months Ending |
$ -2,610.00 |
$ -4,041.00 |
$ 1,172.00 |
$ 4,606.00 |
$ 1,233.00 |
Y / Y Net Cash Flow Growth (TTM) |
- |
- |
-26.89 % |
32800 % |
-53.59 % |
Year on Year Net Cash Flow Growth Overall
Ranking |
# 307 |
# 467 |
# 256 |
# 0 |
# 476 |
Seqeuential Net Cash Flow Change (TTM) |
- |
- |
-74.55 % |
273.56 % |
9.8 % |
Seq. Net Cash Flow Growth (TTM) Overall
Ranking |
# 240 |
# 342 |
# 2 |
# 0 |
# 547 |
Cumulative Net Cash Flow growth
Comment |
Merck And Co Inc realized trailing twelve months net cash outflow of $ -2,610 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 1,233 millions a year ago.
Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 307, from total ranking in previous quarter at 467. |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
|
|
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
|
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 8 |
Sector |
# 22 |
S&P 500 |
# 240 |
|
Cumulative Net Cash Flow growth
Comment |
Merck And Co Inc realized trailing twelve months net cash outflow of $ -2,610 millions, in the Sep 30 2023, compare to Net Cash Flow of $ 1,233 millions a year ago.
Within the Healthcare sector 27 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 307, from total ranking in previous quarter at 467. |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
32800 % |
1120.82 % |
-513.3 % |
|
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 8 |
Sector |
# 22 |
S&P 500 |
# 240 |
|